Since the COVID-19 pandemic, mRNA vaccines have been recognized as the most important platform for infectious disease prevention and continue to be utilized across various fields.

Here, the authors characterize a recombinant virus-like particle polio vaccine with stabilized capsid proteins and show comparable immunogenicity to the current inactivated polio vaccine.

1 School of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, China 2 Department of Oncology, Wuhan Fourth Hospital, Wuhan Orthopedic Hospital, Wuhan, Hubei, China Virus-like ...

New Delhi: Amid the recent outbreak of Human Metapneumovirus (HMPV) in China, an expert from the Indian Medical Association (IMA) on Saturday said the virus does not cause fatalities like Covid-19 but ...